Efficacy and safety of transhepatic arterial chemoembolization with drug-loaded microspheres in unresectable primary liver cancer

Table 1 Basic features included in the study, mean ± SD

Ref.	Cases		Average age (years)		Gender (male/female)		Tumor size (mm)		Child-Pugh grading (A/B)		Newcastle-Ottawa Scale
	DEB-TACE	cTACE	DEB-TACE	cTACE	DEB-TACE	cTACE	DEB-TACE	cTACE	DEB-TACE	cTACE
Chen et al[10]	22	20	N/A	N/A	19/3	17/3	N/A	N/A	15/7	17/3	6
Chi et al[11]	50	50	60.3 ± 12.3		35/15	40/10	42.5 ± 12.3	43.2 ± 11.8	35/15	40/10	8
Ferrer Puchol et al[12]	47	25	59.84 ± 11.216	60.01 ± 12.79	34/13	18/7	61.5 ± 38.4	60.4 ± 39.6	30/17	17/8	7
Huang et al[13]	30	30	59.2 ± 6.3	58.3 ± 6.4	18/12	20/10					6
Lammer et al[14]	93	108	67.3 ± 9.1	67.4 ± 8.8	79/14	95/13	88.9 ± 52.1	89.2 ± 59.3	77/16	89/19	9
Lencioni et al[15]	32	188	67.1 ± 10.56		18/14	100/88	67.2 ± 34.2	65.7 ± 33.6	17/15	100/88	8
Malagari et al[16]	41	43	70.7 ± 6.9	70.0 ± 7.9	31/10	34/9	83.5 ± 27.5	81.0 ± 28.0	23/18	26/17	7
Sacco et al[17]	33	34	70.0 ± 7.7		20/13	21/13	63.1 ± 32.5	60.8 ± 31.1	20/13	22/12	9
Song et al[18]	60	69	61.7 ± 9.8	59.4 ± 11.2	42/18	51/18	42.0 ± 28.0	50.0 ± 31.0	56/4	62/6	7
Wiggermann et al[19]	22	22	69.02+8.1		18/4	19/3	74.4 ± 33.7	69.8 ± 38.1	22/0	22/0	8
You et al[20]	44	43	65	63	30/14	26/17	N/A	N/A	24/20	24/19	8
Dhanasekaran et al[21]	45	26	59.96 ± 11.45	58.96 ± 13.30	35/10	19/7	60.7 ± 45.2	54.9 ± 42.9	28/17	15/11	8

DEB-TACE: Drug-luting beads-transhepatic arterial chemoembolization; cTACE: Conventional transhepatic arterial chemoembolization.